Market revenue in 2023 | USD 193.3 million |
Market revenue in 2030 | USD 324.2 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Therapy Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.47% in 2023. Horizon Databook has segmented the India diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Prevalence of diabetes in India has reached 40.30%, which is expected to boost the incidence of chronic wounds. Furthermore, advancements in healthcare facilities in India have led to an increase in patient volume. According to the Report of the Technical Group on Population Projections for India 2011 – 2036, around 138 million elderly people were present in India in 2021.
Hence, chronic disease burden and increasing geriatric population are expected to drive the market over the forecast period. Several diabetes care device manufacturers are setting up new manufacturing facilities in India owing to the favorable regulatory environment and high population. Several companies are entering into partnerships and collaborations to gain a competitive advantage.
For instance, in October 2022, Healthium Medtech, a Bengaluru-based company, launched several wound dressing products under its wound care portfolio. These dressings are intended to cure venous leg ulcers and diabetic foot ulcers. Thus, such factors are expected to increase the competition in India diabetic foot ulcer treatment market.
Horizon Databook provides a detailed overview of country-level data and insights on the India diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into India diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account